First call for Demonstrator Projects is open

Demonstrator Projects are at the heart of Oncode Accelerator. All parties interested in ​​​​​​​our unique approach are invited to apply for a Demonstrator Project and become a partner to our cancer research network.

Read ​​​​​​​more

Central M​​​​​​​áxima Organoid Biobank launched

Re​​​​​​​searchers at the Princess Máxima Center established a biobank for tumour organoids, which will eventually be available to scientists worldwide. This biobank has the ultimate goal to accelerate the development of new therapies for (childhood) cancer.

Read more

First 11 hospitals  joined R(H)ONDA

Already 11 hospitals are sharing data to fi​​​​​​​ll in the Netherlands Cancer Registry via the Datagateway of Performation. Collecting this real-world data makes it possible to investigate the effectiveness of treatments and how they influence​​​​​​​ quality of life for patients.

Read more

​​​​​​​  New   cleanroom complex for drug development

A state-of-the-art cleanroom complex at Antoni van Leeuwenhoek hospital will house three advanced​​​​​​​ production areas for drug development. Completion is expected at the start of 2025, followed by rigorous validation before becoming operational.

Read more

10+ events

We presented our program

and our workstreams’ and platforms’ capabilities at more than 10 events worldwide, including Bio Europe Spring, Advanced Therapies, and Bio Equity.

Read more

35 partners

We are entering the final stretch of 2024 with 35 partners in Oncode Accelerator: 16 private and 20 public organisations.

In the news

Our program has received significant media attention, capturing widespread interest in our innovative approach. News about the importance of our program was shared in Financieel Dagblad, NRC annex Leiden, and by Nationaal Groeifonds.

Looking back at a successful Annual Meeting 

In May, all public and private partners of our program gathered to discuss how to “Collaborate to Demonstrate”. Over 130 experts in oncological drug development and research joined the event and left the meeting with great excitement to continue our journey towards outsmarting cancer and impacting lives.

Read more

First six patient cohorts selected

Within the Patient Cohort platform, the first six cohorts are selected. This means the clinical data, body materials, and data on quality of life is available for research. One of these cohorts, colon cohort PLCRC, was used for the trend report on colon cancer in the Netherlands.

Read more

Share this article